Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells (original) (raw)

Abstract

We have previously reported that human liver cancer cell lines produce interleukin-8 (IL-8) at high levels. Those tumor cells appeared to express two kinds of IL-8 receptor on their surface. In order to analyze the role of IL-8 on the biological characteristics of those tumor cells, we suppressed IL-8 production from human liver (HuH-7 and HuCC-T1) and pancreatic cancer cell lines (HuP-T4) by treatment with IL-8 antisense oligonucleotides. Suppression of IL-8 production resulted not only in inhibition of cell growth, but also in an increase in the concentrations of some tumor-associated substances such as carbohydrate antigen 19-9 (CA19-9) in the medium. These data indicate that IL-8 produced by human liver and pancreatic tumors may act as an autocrine growth factor and may control the production of some tumor-associated substances. Furthermore, surface expression of sialyl-Lewisa, which is a ligand for ELAM-1 on human umbilical vein endothelial cells (HUVEC), HuCC-T1 and HuP-T4 cells was decreased and the attachment of these tumor cells to HUVEC was inhibited by treatment with IL-8 antisense oligonucleotide. Since the soluble form of CA19-9 (sialyl-Lewisa) was shown to inhibit the tumor cell binding to HUVEC, the decrease in release of CA19-9 into the medium and increase in the expression of sialyl-Lewisa on the cell surface may suggest that IL-8 production from the tumor cells enhances metastatic potential by augmenting the binding activity of the tumor cells to HUVEC. These data demonstrate that a cytokine produced by tumor cells may function as an autocrine growth factor and affect tumor cell dissemination.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. The Third Department of Internal Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama City, Toyama, 930-0152, Japan e-mail: yukihirotym@cc.umin.u-tokyo.ac.jp Tel.: +81-764-34-2281; Fax: +81-764-34-5027, , , , , , JP
    Megumi Miyamoto, Yukihiro Shimizu, Kazuhiko Okada, Yoshiro Kashii, Kiyohiro Higuchi & Akiharu Watanabe

Authors

  1. Megumi Miyamoto
    You can also search for this author inPubMed Google Scholar
  2. Yukihiro Shimizu
    You can also search for this author inPubMed Google Scholar
  3. Kazuhiko Okada
    You can also search for this author inPubMed Google Scholar
  4. Yoshiro Kashii
    You can also search for this author inPubMed Google Scholar
  5. Kiyohiro Higuchi
    You can also search for this author inPubMed Google Scholar
  6. Akiharu Watanabe
    You can also search for this author inPubMed Google Scholar

Additional information

Received: 4 February 1998 / Accepted: 6 May 1998

Rights and permissions

About this article

Cite this article

Miyamoto, M., Shimizu, Y., Okada, K. et al. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells.Cancer Immunol Immunother 47, 47–57 (1998). https://doi.org/10.1007/s002620050503

Download citation